close
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul 16;2008(3):CD006852.
doi: 10.1002/14651858.CD006852.pub2.

Corticosteroids as adjuvant to antiviral treatment in Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults

Teresa Uscategui  1 , Carolyn Doree, Ian J Chamberlain, Martin J Burton
Affiliations

Corticosteroids as adjuvant to antiviral treatment in Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults

Teresa Uscategui et al. Cochrane Database Syst Rev. .

Abstract

Background: Inflammation and oedema of the facial nerve due to viral infection by the herpes zoster virus are implicated in the aetiology and clinical manifestation of Ramsay Hunt syndrome (herpes zoster oticus with facial palsy). Corticosteroids, with their powerful anti-inflammatory effect, have a potential role to play in the reduction or minimisation of nerve damage when administered together with antiviral therapy, and therefore may improve the outcome for patients with Ramsay Hunt syndrome.

Objectives: To determine the effectiveness of corticosteroids as an adjuvant to antiviral therapy in adult patients with Ramsay Hunt syndrome (herpes zoster oticus with facial palsy).

Search strategy: We searched the Cochrane ENT Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), (The Cochrane Library Issue 4, 2007), MEDLINE (1950 to December 2007) and EMBASE (1974 to December 2007), CINAHL (1982 to December 2007), LILACS, KoreaMed, IndMed, PakMediNet, ZETOC, Cambridge Scientific Abstracts (Conference Proceedings Database), ISI Proceedings (Web of Science), the National Research Register (NRR), the UK Clinical Research Network Portfolio Database (UKCRN), the World Health Organization International Clinical Trials Registry Platform (ICTRP), the Research Findings Register (ReFeR) and the metaRegister of Controlled Trials (mRCT).

Selection criteria: All randomised controlled trials in which corticosteroids (by any route of administration at any dosage) were given as an adjuvant to antiviral agents in the treatment of Ramsay Hunt syndrome.

Data collection and analysis: Two reviewers independently assessed eligibility and trial quality of the available studies, whether they were published or unpublished. No trials were found and therefore no data were analysed.

Main results: This is an empty review as no trials were found that fulfilled the inclusion criteria.

Authors' conclusions: Since no randomised controlled trials investigating the use of corticosteroids as an adjuvant to antiviral treatment in Ramsay Hunt syndrome were identified, such studies are needed to assess the effects of such therapy.

PubMed Disclaimer

Conflict of interest statement

None known.

Update of

References

Additional references

Bean 1982
    1. Bean B, Braun C, Balfour HH. Acyclovir therapy for acute herpes zoster. Lancet 1982;2(8290):118‐21. [MEDLINE: ] - PubMed
Dickins 1988
    1. Dickins JR, Smith JT, Graham SS. Herpes zoster oticus: treatment with intravenous acyclovir. Laryngoscope 1988;98(7):776‐9. [MEDLINE: ] - PubMed
Dworkin 2007
    1. Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, et al. Recommendations for the management of herpes zoster. Clinical Infectious Diseases 2007;44(Suppl 1):S1‐26. [MEDLINE: ] - PubMed
Goodman 2006
    1. Schimmer BP, Parker KL. Adrenocorticotropic Hormone; Adrenocortical steroids and their synthetic analogs; Inhibitors of the synthesis and actions of adrenocortical hormones. Goodman and Gilman's: The Pharmacological Basis of Therapeutics. 11th Edition. New York: McGraw‐Hill, 2006:1593‐5.
Gross 2003
    1. Gross G, Schofer H, Wassilew S, Friese K, Timm A, Guthoff R, et al. Herpes zoster guideline of the German Dermatology Society (DDG). Journal of Clinical Virology 2003;26(3):277‐89. [MEDLINE: ] - PubMed
Guess 1985
    1. Guess HA, Broughton DD, Melton LJ, Kurland LT. Epidemiology of herpes zoster in children and adolescents: a population‐based study. Pediatrics 1985;76(4):512‐7. [MEDLINE: ] - PubMed
Hato 2000
    1. Hato N, Kisaki H, Honda N, Gyo K, Murakami S, Yanagihara N. Ramsay Hunt syndrome in children. Annals of Neurology 2000;48(2):254‐6. [MEDLINE: ] - PubMed
Higgins 2006
    1. Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. The Cochrane Library. Vol. Issue 4, Chichester, UK: John Wiley & Sons, Ltd., 2006.
House 1985
    1. House JW, Brackmann DE. Facial nerve grading system. Otolaryngology‐‐Head and Neck Surgery 1985;93(2):146‐7. [MEDLINE: ] - PubMed
Jackson 1997
    1. Jackson JL, Gibbons R, Meyer G, Inouye L. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta‐analysis. Archives of Internal Medicine 1997;157(8):909‐12. [MEDLINE: ] - PubMed
Kaberos 2002
    1. Kaberos A, Balatsouras DG, Korres SG, Kandiloros D. Audiological assessment in Ramsay Hunt syndrome. Annals of Otology, Rhinology & Laryngology 2002;111(1):68‐76. [MEDLINE: ] - PubMed
Kinishi 2001
    1. Kinishi M, Amatsu M, Mohri M, Saito M, Hasegawa T, Hasegawa S. Acyclovir improves recovery rate of facial nerve palsy in Ramsay Hunt syndrome. Auris Nasus Larynx 2001;28(3):223‐6. [MEDLINE: ] - PubMed
Lampee 1986
    1. Lampee KF (ed.). Acyclovir sodium. AMA Drug Evaluations. Sixth edition. Chicago, USA: American Medical Assocation, 1986:1623‐5.
Murakami 1997
    1. Murakami S, Hato N, Horiuchi J, Honda N, Gyo K, Yanagihara N. Treatment of Ramsay Hunt syndrome with acyclovir‐prednisone: significance of early diagnosis and treatment. Annals of Neurology 1997;41(3):353‐7. [MEDLINE: ] - PubMed
Murakami 1998
    1. Murakami S, Honda N, Mizobuchi M, Nakashiro Y, Hato N, Gyo K. Rapid diagnosis of varicella zoster virus infection in acute facial palsy. Neurology 1998;51(4):1202‐5. [MEDLINE: ] - PubMed
Oxman 1995
    1. Oxman MN. Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology 1995;45(12 (Suppl 8)):S41‐6. [MEDLINE: ] - PubMed
Peterslund 1981
    1. Peterslund NA, Seyer‐Hansen K, Ipsen J, Esmann V, Schonheyder H, Juhl H. Acyclovir in herpes zoster. Lancet 1981;2(8251):827‐30. [MEDLINE: ] - PubMed
Ramsay Hunt 1907
    1. Ramsay Hunt J. On herpetic inflammations of the geniculate ganglion. A new syndrome and its complications. Journal of Nervous Mental Diseases 1907;34:73‐96.
Sweeney 2001
    1. Sweeney CJ, Gilden DH. Ramsay Hunt syndrome. Journal of Neurology, Neurosurgery and Psychiatry 2001;71(2):149‐54. [MEDLINE: ] - PMC - PubMed
Uri 2003
    1. Uri N, Greenberg E, Kitzes‐Cohen R, Doweck I. Acyclovir in the treatment of Ramsay Hunt syndrome. Otolaryngology‐‐Head and Neck Surgery 2003;129(4):379‐81. [MEDLINE: ] - PubMed
Whitley 1996
    1. Whitley RJ, Weiss H, Gnann JW, Tyring S, Mertz GJ, Pappas PG, et al. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo‐controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Annals of Internal Medicine 1996;125(5):376‐83. [MEDLINE: ] - PubMed
Wood 1994
    1. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine 1994;330(13):896‐900. [MEDLINE: ] - PubMed
Wood 1996
    1. Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta‐analysis of placebo‐controlled trials. Clinical Infectious Diseases 1996;22(2):341‐7. [MEDLINE: ] - PubMed

Publication types

MeSH terms